Texas Skin Cancer Misdiagnosis Lawyer

Trusted Texas Medical Attorneys for Delayed Melanoma Diagnosis Claims

Understanding Melanoma and Skin Cancer Misdiagnosis in Texas

Skin cancer misdiagnosis occurs when a healthcare provider fails to identify a malignant lesion, misreads pathology results, or delays the testing needed to catch the disease before it spreads. In Texas, these cases often involve melanoma, which is the most dangerous form of skin cancer. This type of cancer develops in the cells responsible for skin pigment. It can spread rapidly to other organs if not detected early. This failure constitutes medical malpractice when the provider deviates from the accepted standard.

What makes skin cancer misdiagnosis cases different from many other cancer claims is visibility. Unlike internal cancers that require imaging or bloodwork to detect, skin cancer often presents directly on the surface of the body. A changing mole, an unusual spot, or a lesion that bleeds or evolves over time are all warning signs. If a patient brings these concerns to a doctor and the doctor dismisses them without proper testing, the evidence of what was missed may have been clear and visible.

One of the most harmful outcomes in these cases is a false negative. This is a test result or clinical assessment that incorrectly tells a patient they are cancer-free. A false negative can create a dangerous sense of security. The patient goes home believing everything is fine, while the cancer continues to grow and potentially metastasize, which means it spreads to other parts of the body. A skin cancer misdiagnosis attorney can help determine whether that reassurance was the result of negligence.

The emotional weight of learning that earlier action could have changed the outcome is significant. Many families come to us carrying guilt, anger, and grief. They replay the appointments, wondering if they should have pushed harder. As a melanoma lawyer experienced in these claims, we understand what is at stake medically and personally, and we work to uncover whether the standard of care was met.

Common Medical Errors Leading to Delayed Skin Cancer Diagnosis

Common errors include dismissing a suspicious mole as benign without performing a biopsy, choosing the wrong biopsy technique, misreading pathology slides, or failing to refer the patient to a specialist. These mistakes can each independently cause a dangerous delay, and in some cases, several of them compound in the same case.

The misdiagnosis of skin cancer often begins at the primary care level. A patient may point out a changing mole or an unusual spot during a routine visit, only to have the doctor dismiss it as a harmless age spot or a benign growth. Without ordering a biopsy or referring the patient to a dermatologist, the opportunity for early detection is lost. Patients have a right to access their own medical records, and the Texas Medical Board’s patient information guidelines outline how those records can be obtained to understand what was documented during those visits.

Even when a biopsy is performed, the type of biopsy matters. A shave biopsy, a technique where only the surface layers of skin are removed, may not capture the full depth of a melanoma. If the lesion is suspicious for invasive cancer, the standard of care may require a punch biopsy, which removes a deeper cylindrical core of tissue, or an excisional biopsy, which removes the entire lesion with a margin of surrounding skin. Choosing the wrong method can lead to incomplete staging and an inaccurate picture of how far the cancer has progressed.

Here are some of the most common failures a Texas melanoma attorney may investigate:

• Dismissal without testing: A family doctor or primary care physician tells the patient a lesion is “nothing to worry about” without performing or ordering a biopsy.
• Inadequate biopsy technique: A shave biopsy is performed when depth analysis required a punch or excisional biopsy, resulting in an incomplete sample.
• Pathology misinterpretation: A dermatopathologist, the specialist who reads skin tissue slides under a microscope, misclassifies a malignant sample as benign.
• Lost or unreported results: The pathology report, which is the lab document detailing whether the tissue sample contains cancerous cells, never reaches the treating physician or the patient.
• Failure to refer: A general practitioner does not send the patient to a dermatologist despite warning signs that exceed their diagnostic expertise.
• Inadequate surgical margins: The surgeon fails to remove enough surrounding tissue during excision, leaving cancer cells behind that can spread.

The Role of Pathology in Misdiagnosis

Even when the right biopsy is performed, errors can still occur in the lab. A dermatopathologist is a doctor who specializes in examining skin tissue samples under a microscope. They may misread the slides and classify a malignant melanoma as a benign mole or atypical nevus. This type of false negative at the pathology level can be especially harmful because it gives both the treating doctor and the patient a false sense of security.

The pathology report is the document that drives the next steps in treatment. If it incorrectly states the tissue is non-cancerous, no further treatment is ordered. Months or even years may pass before the cancer is re-identified, often at a far more advanced and dangerous stage. Our team reviews pathology records closely to determine whether errors at the lab level contributed to the delay.

The Standard of Care: How Melanoma Should Be Diagnosed

The standard of care requires a physician to perform a thorough skin exam, apply recognized screening criteria to evaluate suspicious lesions, and promptly order a biopsy for any irregularity that could indicate malignancy. When a doctor fails to follow these steps, it may constitute a breach of the accepted medical standard, which is the foundation of a failure to diagnose skin cancer claim. Such negligence can alter a patient’s entire prognosis.

One of the most widely recognized screening tools is the ABCDE rule, a clinical framework validated in peer-reviewed dermatology research. This rule gives physicians a structured way to evaluate moles and lesions based on five characteristics:

• Asymmetry: One half of the mole does not match the other.
• Border: The edges are irregular, ragged, or blurred.
• Color: The color is uneven, with shades of brown, black, tan, red, or blue.
• Diameter: The spot is larger than 6 millimeters (about the size of a pencil eraser).
• Evolving: The mole is changing in size, shape, or color over time.

Any one of these features should prompt further evaluation. The presence of multiple indicators typically calls for immediate diagnostic tests. These often include an excisional biopsy that removes the entire lesion and a margin of healthy tissue for complete analysis.

Research into diagnostic accuracy highlights why these standards matter. A systematic review and meta-analysis published through PubMed Central examined diagnostic accuracy among family physicians and dermatologists, confirming that initial misidentification of melanoma remains a real and documented problem. This does not excuse the error. It confirms that the medical system is aware of the risk, which makes adherence to screening protocols even more important.

When a primary care physician encounters a lesion that raises concern, the standard of care typically requires a referral to a dermatologist. Referrals may also lead to necessary imaging studies to check for spread. Failing to make that referral, especially when the patient has expressed concern about changes to a mole, can be the critical breakdown that allows melanoma to advance undetected. Under Texas Civil Practice and Remedies Code Chapter 74, a Texas malpractice lawyer must establish this breach through qualified expert testimony to move the case forward.

Proving Liability in Texas Melanoma Malpractice Cases

To prove liability, you must demonstrate that a doctor-patient relationship existed, the doctor breached the standard of care by failing to properly diagnose or act on warning signs, and that this breach directly caused the cancer to progress or reduced the patient’s chance of survival.

Causation is often the most contested element in these cases. It is not enough to show that a doctor missed the diagnosis. We must also establish that the delay in diagnosis allowed the cancer to spread, a process called metastasis. This occurs when melanoma cells move beyond the original site into the lymph nodes or distant organs like the lungs, liver, or brain. The defense often argues that the cancer was already aggressive and the outcome would have been the same regardless.

This is why melanoma staging, the system used to describe the severity and spread of the cancer, matters so much in litigation. Melanoma is classified in stages from Stage I through Stage IV. Stage I melanoma is localized to the skin and has a high survival rate, often above 95%. Stage IV melanoma has spread to distant organs and carries a dramatically lower survival rate. If we can demonstrate through medical records and expert analysis that the stage progression from early to late disease occurred during the window of missed diagnosis, we can establish that the delay caused real, measurable harm.

Liability in these cases can extend to multiple parties. A general practitioner who failed to refer, a dermatologist who dismissed a suspicious lesion, or a laboratory that misread pathology slides may each bear responsibility. Under Texas Civil Practice and Remedies Code § 74.351, a qualified expert report must be served within 120 days after the date each defendant’s original answer is filed to identify the specific breach and its connection to the patient’s worsened outcome. Our team, which includes in-house medical staff and former defense attorneys, works to build that connection from day one to secure necessary damages or pursue a wrongful death claim. If you believe your diagnosis was delayed, speaking with a skin cancer negligence lawyer can help clarify whether you have grounds to sue for delayed diagnosis.

Compensation and Damages for Delayed Diagnosis Victims

Victims may recover economic damages for medical bills and lost wages, as well as non-economic damages for pain, suffering, disfigurement from aggressive late-stage treatments, and mental anguish. Patients may seek economic damages for the financial costs tied directly to the delay, while non-economic damages address the physical and emotional toll.

When melanoma advances because of a missed diagnosis, the cost of treatment increases significantly. What might have required a simple excision at Stage I can escalate to immunotherapy, radiation, or repeated surgeries at later stages. A Texas skin cancer lawyer can help pursue compensation that accounts for both the care already received and the treatment still ahead, protecting your future financial security.

Damage Category	Examples
Past medical expenses	Surgeries, biopsies, hospital stays, consultations
Future medical costs	Immunotherapy, radiation, ongoing monitoring, palliative care
Lost wages and earning capacity	Time missed from work; reduced ability to earn in the future
Pain and suffering	Physical pain from aggressive treatments that could have been minor procedures
Disfigurement	Scarring from wide excisions or reconstructive surgery
Emotional distress and mental anguish	Anxiety, depression, fear of recurrence, loss of quality of life
Wrongful death	Compensation for families who lost a loved one to preventable melanoma progression

Under Texas Civil Practice and Remedies Code § 74.301, non-economic damages in medical malpractice cases are subject to statutory caps. Economic damages, however, are not capped, and in cases involving late-stage melanoma treatment, those costs can be substantial.

Contact the Texas Misdiagnosis Attorneys at Hastings Law Firm Today for Help

A delayed melanoma diagnosis is often a preventable tragedy. When a doctor had the opportunity to catch skin cancer early and did not, you deserve to know why, and you deserve to understand your legal options.

Hastings Law Firm represents patients and families across Texas who have been harmed by diagnostic failures. Our team includes a board-certified founder, in-house nurse practitioners, and former defense lawyers who know how hospitals and insurers approach these cases. We prepare every case for trial, because that preparation is what drives fair results.

There are no upfront fees. We work on a contingency basis, which means you pay nothing unless we recover compensation on your behalf. If you or a loved one experienced a delayed or missed skin cancer diagnosis, contact us for a free, confidential case evaluation. Let us help you find the answers you deserve.